Titre : Tumeurs de l'appareil digestif

Tumeurs de l'appareil digestif : Questions médicales fréquentes

Termes MeSH sélectionnés :

Network Meta-Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs de l'appareil digestif : Questions médicales les plus fréquentes", "headline": "Tumeurs de l'appareil digestif : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs de l'appareil digestif : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-21", "dateModified": "2025-02-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs de l'appareil digestif" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies de l'appareil digestif", "url": "https://questionsmedicales.fr/mesh/D004066", "about": { "@type": "MedicalCondition", "name": "Maladies de l'appareil digestif", "code": { "@type": "MedicalCode", "code": "D004066", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tumeurs des voies biliaires", "alternateName": "Biliary Tract Neoplasms", "url": "https://questionsmedicales.fr/mesh/D001661", "about": { "@type": "MedicalCondition", "name": "Tumeurs des voies biliaires", "code": { "@type": "MedicalCode", "code": "D001661", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.301.120" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tumeurs des canaux biliaires", "alternateName": "Bile Duct Neoplasms", "url": "https://questionsmedicales.fr/mesh/D001650", "about": { "@type": "MedicalCondition", "name": "Tumeurs des canaux biliaires", "code": { "@type": "MedicalCode", "code": "D001650", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.301.120.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tumeurs du cholédoque", "alternateName": "Common Bile Duct Neoplasms", "url": "https://questionsmedicales.fr/mesh/D003138", "about": { "@type": "MedicalCondition", "name": "Tumeurs du cholédoque", "code": { "@type": "MedicalCode", "code": "D003138", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.301.120.250.250" } } } ] }, { "@type": "MedicalWebPage", "name": "Tumeurs du cholédoque", "alternateName": "Common Bile Duct Neoplasms", "url": "https://questionsmedicales.fr/mesh/D003138", "about": { "@type": "MedicalCondition", "name": "Tumeurs du cholédoque", "code": { "@type": "MedicalCode", "code": "D003138", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.301.120.250.250" } } }, { "@type": "MedicalWebPage", "name": "Tumeurs de la vésicule biliaire", "alternateName": "Gallbladder Neoplasms", "url": "https://questionsmedicales.fr/mesh/D005706", "about": { "@type": "MedicalCondition", "name": "Tumeurs de la vésicule biliaire", "code": { "@type": "MedicalCode", "code": "D005706", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.301.120.401" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Tumeurs de l'appareil digestif", "alternateName": "Digestive System Neoplasms", "code": { "@type": "MedicalCode", "code": "D004067", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Anne Couvelard", "url": "https://questionsmedicales.fr/author/Anne%20Couvelard", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Beaujon/Bichat Hospitals (APHP.Nord), Université Paris-Cité, Clichy/Paris, France." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Jérôme Cros", "url": "https://questionsmedicales.fr/author/J%C3%A9r%C3%B4me%20Cros", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Beaujon/Bichat Hospitals (APHP.Nord), Université Paris-Cité, Clichy/Paris, France." } }, { "@type": "Person", "name": "Jinbo Liu", "url": "https://questionsmedicales.fr/author/Jinbo%20Liu", "affiliation": { "@type": "Organization", "name": "Department of Clinical Laboratory, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. Electronic address: liulab2019@163.com." } }, { "@type": "Person", "name": "Guido Rindi", "url": "https://questionsmedicales.fr/author/Guido%20Rindi", "affiliation": { "@type": "Organization", "name": "Anatomic Pathology Section, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Roma, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Kenward-Roger-type corrections for inference methods of network meta-analysis and meta-regression.", "datePublished": "2023-07-03", "url": "https://questionsmedicales.fr/article/37399845", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jrsm.1652" } }, { "@type": "ScholarlyArticle", "name": "Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis.", "datePublished": "2024-09-18", "url": "https://questionsmedicales.fr/article/39293856", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1183/16000617.0046-2024" } }, { "@type": "ScholarlyArticle", "name": "Topical anti-inflammatory treatments for eczema: network meta-analysis.", "datePublished": "2024-08-06", "url": "https://questionsmedicales.fr/article/39105474", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD015064.pub2" } }, { "@type": "ScholarlyArticle", "name": "Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.", "datePublished": "2023-08-31", "url": "https://questionsmedicales.fr/article/37650547", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD013730.pub2" } }, { "@type": "ScholarlyArticle", "name": "Percutaneous coronary intervention in calcified stenoses: a protocol for a systematic review with meta-analysis, trial sequential analysis and network meta-analysis.", "datePublished": "2022-09-02", "url": "https://questionsmedicales.fr/article/36691161", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-063884" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil digestif", "item": "https://questionsmedicales.fr/mesh/D004066" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs de l'appareil digestif", "item": "https://questionsmedicales.fr/mesh/D004067" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs de l'appareil digestif - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs de l'appareil digestif", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs de l'appareil digestif", "description": "Comment diagnostiquer une tumeur digestive ?\nQuels tests sanguins sont utilisés ?\nQuelle est l'importance de l'endoscopie ?\nQuand faire un scanner abdominal ?\nQuels symptômes nécessitent un diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs de l'appareil digestif", "description": "Quels sont les symptômes courants des tumeurs digestives ?\nComment se manifeste une obstruction intestinale ?\nLes tumeurs peuvent-elles causer des saignements ?\nQuels signes indiquent une tumeur de l'estomac ?\nLes tumeurs peuvent-elles provoquer des troubles digestifs ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs de l'appareil digestif", "description": "Comment prévenir les tumeurs digestives ?\nLe dépistage est-il important ?\nQuels aliments éviter pour réduire le risque ?\nLe surpoids est-il un facteur de risque ?\nFaut-il éviter l'alcool ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs de l'appareil digestif", "description": "Quels traitements sont disponibles pour les tumeurs digestives ?\nQuand la chirurgie est-elle recommandée ?\nQuel rôle joue la chimiothérapie ?\nLa radiothérapie est-elle efficace ?\nQu'est-ce que l'immunothérapie ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs de l'appareil digestif", "description": "Quelles sont les complications possibles des tumeurs digestives ?\nComment les tumeurs affectent-elles la nutrition ?\nLes tumeurs peuvent-elles causer des douleurs chroniques ?\nQuelles sont les conséquences des métastases ?\nLes infections sont-elles une complication ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs de l'appareil digestif", "description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme augmente-t-il le risque ?\nLes antécédents familiaux sont-ils importants ?\nL'alimentation joue-t-elle un rôle ?\nLe stress est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D004067?mesh_terms=Network+Meta-Analysis&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une tumeur digestive ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par endoscopie, imageries (IRM, scanner) et biopsie." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs tumoraux comme le CEA et l'AFP peuvent être mesurés." } }, { "@type": "Question", "name": "Quelle est l'importance de l'endoscopie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'endoscopie permet de visualiser directement les lésions et de prélever des échantillons." } }, { "@type": "Question", "name": "Quand faire un scanner abdominal ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un scanner est recommandé pour évaluer l'extension de la tumeur et les métastases." } }, { "@type": "Question", "name": "Quels symptômes nécessitent un diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales persistantes, des saignements ou des changements de transit." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des tumeurs digestives ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleurs abdominales, perte de poids, nausées et vomissements." } }, { "@type": "Question", "name": "Comment se manifeste une obstruction intestinale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des douleurs, des vomissements et une incapacité à évacuer les selles." } }, { "@type": "Question", "name": "Les tumeurs peuvent-elles causer des saignements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des saignements peuvent survenir dans les selles ou par voie orale selon la localisation." } }, { "@type": "Question", "name": "Quels signes indiquent une tumeur de l'estomac ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs épigastriques, des nausées, et une sensation de satiété précoce peuvent indiquer une tumeur." } }, { "@type": "Question", "name": "Les tumeurs peuvent-elles provoquer des troubles digestifs ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des troubles comme des ballonnements, des diarrhées ou de la constipation." } }, { "@type": "Question", "name": "Comment prévenir les tumeurs digestives ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, l'exercice régulier et l'évitement du tabac sont conseillés." } }, { "@type": "Question", "name": "Le dépistage est-il important ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce peut aider à détecter les tumeurs à un stade précoce." } }, { "@type": "Question", "name": "Quels aliments éviter pour réduire le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de limiter les viandes transformées et les aliments riches en graisses saturées." } }, { "@type": "Question", "name": "Le surpoids est-il un facteur de risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité est un facteur de risque pour plusieurs types de tumeurs digestives." } }, { "@type": "Question", "name": "Faut-il éviter l'alcool ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consommation excessive d'alcool augmente le risque de cancers digestifs." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les tumeurs digestives ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle recommandée ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est souvent recommandée pour retirer la tumeur si elle est localisée." } }, { "@type": "Question", "name": "Quel rôle joue la chimiothérapie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chimiothérapie est utilisée pour réduire la taille des tumeurs ou traiter les métastases." } }, { "@type": "Question", "name": "La radiothérapie est-elle efficace ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être utilisée pour traiter les tumeurs non opérables ou réduire la douleur." } }, { "@type": "Question", "name": "Qu'est-ce que l'immunothérapie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'immunothérapie stimule le système immunitaire pour combattre les cellules tumorales." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des tumeurs digestives ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des saignements, des obstructions intestinales et des métastases." } }, { "@type": "Question", "name": "Comment les tumeurs affectent-elles la nutrition ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer des malabsorption et des carences nutritionnelles." } }, { "@type": "Question", "name": "Les tumeurs peuvent-elles causer des douleurs chroniques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des douleurs chroniques dues à l'invasion des tissus environnants." } }, { "@type": "Question", "name": "Quelles sont les conséquences des métastases ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les métastases peuvent affecter d'autres organes, compliquant le traitement et le pronostic." } }, { "@type": "Question", "name": "Les infections sont-elles une complication ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections peuvent survenir, surtout après une chirurgie ou en cas d'immunosuppression." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les antécédents familiaux, le tabagisme et l'alimentation." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque reconnu pour plusieurs cancers digestifs." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils importants ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancers digestifs augmentent le risque individuel." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en fibres et pauvre en graisses peut réduire le risque." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le stress n'est pas un facteur direct, mais il peut influencer des comportements à risque." } } ] } ] }

Sources (10000 au total)

Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis.

With recent advancements in bronchoscopic procedures, data on the best modality to sample peripheral pulmonary lesions (PPLs) is lacking, especially comparing bronchoscopy with computed tomography-gui... We performed a meta-analysis, pairwise meta-analysis and network meta-analysis on studies reporting diagnostic yield and complications with the use of CT-TBNA, radial endobronchial ultrasound (rEBUS),... We included 363 studies. The overall pooled diagnostic yield was 78.1%, the highest with CT-TBNA (88.9%), followed by RAB (84.8%) and the least with rEBUS (72%). In the pairwise meta-analysis, only rE... Although CT-TBNA is the most effective approach to sample PPLs, RAB has a comparable diagnostic yield with a lesser complication rate. Further prospective studies are needed comparing CT-TBNA and RAB....

Topical anti-inflammatory treatments for eczema: network meta-analysis.

Eczema (atopic dermatitis) is the most burdensome skin condition worldwide and cannot currently be prevented or cured. Topical anti-inflammatory treatments are used to control eczema symptoms, but the... To compare and rank the efficacy and safety of topical anti-inflammatory treatments for people with eczema using a network meta-analysis.... We searched the Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase and trial registries on 29 June 2023, and checked the reference lists of included studies.... We included within-participant or between-participant randomised controlled trials (RCTs) in people of any age with eczema of any severity, but excluded trials in clinically infected eczema, seborrhoe... We used standard Cochrane methods. Primary outcomes were patient-reported eczema symptoms, clinician-reported eczema signs and investigator global assessment. Secondary outcomes were health-related qu... We included 291 studies involving 45,846 participants with the full spectrum of eczema severity, mainly conducted in high-income countries in secondary care settings. Most studies included adults, wit... Potent TCS, JAK inhibitors and tacrolimus 0.1% were consistently ranked as amongst the most effective topical anti-inflammatory treatments for eczema and PDE-4 inhibitors as amongst the least effectiv...

Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.

Despite considerable improvement in outcomes for preterm infants, rates of bronchopulmonary dysplasia (BPD) remain high, affecting an estimated 33% of very low birthweight infants, with corresponding ... To determine whether differences in efficacy and safety exist between high-dose dexamethasone, moderate-dose dexamethasone, low-dose dexamethasone, hydrocortisone, and placebo in the prevention of BPD... We searched the Cochrane Library for all systematic reviews of systemic corticosteroids for the prevention of BPD and searched for completed and ongoing studies in the following databases in January 2... We included randomized controlled trials (RCTs) in preterm infants (< 37 weeks' gestation) at risk for BPD that evaluated systemic corticosteroids (high-dose [≥ 4 mg/kg cumulative dose] dexamethasone,... Our main information sources were the systematic reviews, with reference to the original manuscript only for data not included in these reviews. Teams of two paired review authors independently perfor... We included 59 studies, involving 6441 infants, in our analyses. Only six of the included studies provided direct comparisons between any of the treatment (dexamethasone or hydrocortisone) groups, for... Low-dose dexamethasone increased the risk for cerebral palsy (RR 1.92, 95% CI 1.12 to 3.28; moderate-certainty evidence) compared with control. Hydrocortisone may decrease the risk of major neurosenso... No effect was observed for the outcomes of major neurosensory disability or cerebral palsy. The evidence for the primary outcomes was of overall low certainty, with notable deductions for imprecision ... While early treatment with moderate-dose dexamethasone or late treatment with high-dose dexamethasone may lead to the best effects for survival without BPD, the certainty of the evidence is low. There...

Percutaneous coronary intervention in calcified stenoses: a protocol for a systematic review with meta-analysis, trial sequential analysis and network meta-analysis.

Severely calcified coronary stenoses are difficult to treat with percutaneous coronary interventions. The presence of severe calcifications complicates lesion preparation, advancement of stents and ac... We will conduct a systematic review of randomised trials enrolling patients with calcified coronary artery disease undergoing percutaneous coronary intervention. We will investigate any percutaneous t... No ethics approval is required for this study. The results will be published in a peer-reviewed journal in this field.... CRD42021226034....

Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.

Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects mainly young adults (two to three times more frequently in women than in men) and causes significant disability ... To compare adverse effects of immunotherapies for people with MS or clinically isolated syndrome (CIS), and to rank these treatments according to their relative risks of adverse effects through networ... We searched CENTRAL, PubMed, Embase, two other databases and trials registers up to March 2022, together with reference checking and citation searching to identify additional studies.... We included participants 18 years of age or older with a diagnosis of MS or CIS, according to any accepted diagnostic criteria, who were included in randomized controlled trials (RCTs) that examined o... We used standard Cochrane methods for data extraction and pairwise meta-analyses. For NMAs, we used the netmeta suite of commands in R to fit random-effects NMAs assuming a common between-study varian... This NMA included 123 trials with 57,682 participants... We found mostly low and very low-certainty evidence that drugs used to treat MS may not increase SAEs, but may increase withdrawals compared with placebo. The results suggest that there is no importan...

Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis.

A comprehensive network meta-analysis comparing the effects of individual sodium-glucose cotransporter 2 (SGLT2) inhibitors on patients with and without comorbidities including diabetes mellitus (DM),... We searched PubMed, Embase, Cochrane, and ClinicalTrials.gov for randomized controlled trials up to March 28, 2023. Network meta-analysis using a random-effects model was conducted to calculate risk r... A total of fourteen trials with 75,334 patients were analyzed. Among these, 40,956 had taken SGLT2 inhibitors and 34,378 had not. One of the main results with particular findings was empagliflozin use... Our network meta-analysis revealed that empagliflozin users with diabetes experienced a lower risk of dying from any cause than those using dapagliflozin. Additionally, canagliflozin users demonstrate... PROSPERO [CRD42022361906]....

A network meta-analysis of surgical treatments of complete rectal prolapse.

Surgical treatment of complete rectal prolapse can be undertaken via an abdominal or a perineal approach. The present network meta-analysis aimed to compare the outcomes of different abdominal and per... A PRISMA-compliant systematic review of PubMed, Scopus, and Web of Science was conducted. Randomized clinical trials comparing two or more procedures for the treatment of complete rectal prolapse were... Nine randomized controlled trials with 728 patients were included. The follow-up ranged between 12 and 47 months. Posterior mesh rectopexy had significantly lower odds of recurrence than did the Altem... Posterior mesh rectopexy ranked best with the lowest recurrence while perineal procedures ranked worst with the highest recurrence rates....

Efficacy and safety of COVID-19 vaccines: A network meta-analysis.

Several vaccines showed a good safety profile and significant efficacy against COVID-19. Moreover, in the absence of direct head to head comparison between COVID-19 vaccines, a network meta-analysis t... Databases PubMed, CENTRAL, medRxiv, and clinicaltrials.gov were searched. Studies were included if they were placebo-controlled clinical trials and reported the safety profile and/or effectiveness of ... Forty-nine clinical trials that included 421,173 participants and assessed 28 vaccines were included in this network meta-analysis. The network meta-analysis showed that Pfizer is the most effective i... We found that almost all of the vaccines included in this study crossed the threshold of 50% efficacy. However, some of them did not reach the previously mentioned threshold against the B.1.351 varian...